Yongning Jia
Overview
Explore the profile of Yongning Jia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gan X, Jia Y, Shan F, Ying X, Li S, Zhang Y, et al.
BMC Cancer
. 2025 Mar;
25(1):401.
PMID: 40045265
Background: Perioperative chemotherapy combined with D2 radical gastrectomy has been proven to be the standard treatment for local advanced gastric cancer. However, tumor regression grading (TRG) is the only neoadjuvant...
2.
Wang Y, Lei X, Shan F, Li S, Jia Y, Miao R, et al.
BMC Cancer
. 2024 Aug;
24(1):1074.
PMID: 39215275
Background: This study was conducted to investigate the long-term outcomes of laparoscopic total gastrectomy (LTG) versus open total gastrectomy (OTG) in patients with advanced gastric cancer (AGC) after neoadjuvant chemotherapy...
3.
Wang Y, Gan X, Cheng X, Jia Y, Wang G, Tang X, et al.
Clin Transl Med
. 2024 Aug;
14(8):e1754.
PMID: 39095325
Background: Although it is traditionally believed that ATP binding cassette subfamily C member 2 (ABCC2) is a multidrug resistance-associated protein correlated with a worse prognosis, our previous and several other...
4.
Gao X, Ji K, Jia Y, Shan F, Chen Y, Xu N, et al.
Nat Med
. 2024 May;
30(7):1943-1951.
PMID: 38778212
Treatment with anti-programmed cell death protein 1 (PD-1) therapy and chemotherapy prolongs the survival of patients with unresectable advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. The benefit from...
5.
Li B, Wang Y, Wu Z, Shan F, Li S, Jia Y, et al.
Surg Endosc
. 2024 Jan;
38(3):1523-1532.
PMID: 38272976
Background: There is no optimal reconstruction method after proximal gastrectomy. The valvuloplastic esophagogastrostomy can reduce postoperative reflux esophagitis, but it is technically complex with a long operation time. The gastric...
6.
Wang Y, Tang L, Ying X, Li J, Shan F, Li S, et al.
Ann Surg Oncol
. 2023 Nov;
31(2):774-782.
PMID: 37993745
Background: Prognosis prediction of patients with gastric cancer after neoadjuvant chemotherapy is suboptimal. This study aims to develop and validate a dynamic radiomic model for prognosis prediction of patients with...
7.
Li B, Miao R, Shan F, Li S, Jia Y, Xue K, et al.
World J Surg Oncol
. 2023 Jul;
21(1):204.
PMID: 37434202
Background: The prognosis of gastric cancer (GC) patients with positive peritoneal cytology (CY1) without other distant metastasis is poor, and there are no standard treatment strategies. Our study aimed to...
8.
Lei X, Wang Y, Shan F, Li S, Jia Y, Miao R, et al.
J Chin Med Assoc
. 2023 Jun;
86(8):717-724.
PMID: 37273199
Background: At present, there is no consensus on whether preoperative immunotherapy (PIT) without chemotherapy followed by surgery could benefit patients with advanced gastric cancer (AGC). Here, we report a six-case...
9.
Wang Y, Hong F, Li S, Shan F, Jia Y, Miao R, et al.
Chin J Cancer Res
. 2023 May;
35(2):163-175.
PMID: 37180833
Objective: To explore the change and feasibility of surgical techniques of laparoscopic transhiatal (TH)-lower mediastinal lymph node dissection (LMLND) for adenocarcinoma of the esophagogastric junction (AEG) according to Idea, Development,...
10.
Yang Y, Ruge F, Ji K, Jia S, Jia Y, Sanders A, et al.
Anticancer Res
. 2023 Mar;
43(4):1463-1475.
PMID: 36974802
Background/aim: Activated leukocyte cell adhesion molecule (ALCAM/CD166), a member of the immunoglobulin superfamily, has been shown to regulate cell adhesion through both homotypic and heterotypic interactions. In cancer, it might...